Maximilian Vidovic
Dresden, SN 01307, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Between guidelines and reality: expert neurologists' perspectives on structural resources for ALS care in Germany.
Journal: Neurological research and practice
Published: December 09, 2025
Methotrexate therapy as a promising long-term treatment approach for immune-mediated adverse reactions of tofersen in SOD1-ALS: a case report.
Journal: Journal of neurology
Published: September 07, 2025
Self-assessment of amyotrophic lateral sclerosis functional rating scale on the patient's smartphone proves to be non-inferior to clinic data capture.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: February 22, 2025
Targeted Proteomics upon Treatment with Tofersen Identifies Novel Response Markers for Superoxide Dismutase 1-Linked Amyotrophic Lateral Sclerosis.
Journal: Annals of neurology
Published: December 16, 2024
SOD1 gene screening in ALS - frequency of mutations, patients' attitudes to genetic information and transition to tofersen treatment in a multi-center program.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: September 13, 2024
Patients' and caregivers' perception of multidimensional and palliative care in amyotrophic lateral sclerosis - protocol of a German multicentre study.
Journal: Neurological research and practice
Published: April 25, 2024
Comparative analysis of neurofilaments and biomarkers of muscular damage in amyotrophic lateral sclerosis.
Journal: Brain communications
Published: April 10, 2024
Serum neurofilament light chain in distinct phenotypes of amyotrophic lateral sclerosis: A longitudinal, multicenter study.
Journal: European journal of neurology
Published: February 25, 2024
Clinical and patient-reported outcomes and neurofilament response during tofersen treatment in SOD1-related ALS-A multicenter observational study over 18 months.
Journal: Muscle & nerve
Published: January 19, 2024
Effects of tofersen treatment in patients with SOD1-ALS in a "real-world" setting - a 12-month multicenter cohort study from the German early access program.
Journal: EClinicalMedicine
Published: November 06, 2023
Macrophage inclusions in cerebrospinal fluid following treatment initiation with antisense oligonucleotide therapies in motor neuron diseases.
Journal: Neurological research and practice
Published: October 09, 2023
Last Updated: 09/26/2026